Literature DB >> 20496139

Sudden bilateral sensorineural hearing loss as the presenting symptom of meningeal carcinomatosis of gastric cancer: report of a case.

Tetsuro Ohno1, Yozo Yokoyama, Ryuusuke Aihara, Erito Mochiki, Takayuki Asao, Hiroyuki Kuwano.   

Abstract

Meningeal carcinomatosis is the diffuse infiltration of the meninges by metastatic carcinoma. A 62-year-old man presented with a sudden onset of profound hearing loss affecting both ears. Brain magnetic resonance imaging showed increased signal intensity on T1-weighted images of both vestibulocochlear nerves. Upper gastrointestinal endoscopy revealed a large type 3 gastric cancer, and the pathological diagnosis was poorly differentiated adenocarcinoma. Although combination chemotherapy with oral S-1 and weekly paclitaxel and radiation therapy were performed, the patient's condition gradually worsened, and he eventually died 12 weeks after the onset of deafness. Isolated bilateral hearing loss is therefore considered to be a rare first manifestation of meningeal carcinomatosis.

Entities:  

Mesh:

Year:  2010        PMID: 20496139     DOI: 10.1007/s00595-009-4099-1

Source DB:  PubMed          Journal:  Surg Today        ISSN: 0941-1291            Impact factor:   2.549


  19 in total

1.  Combination intraventricular chemotherapy for meningeal neoplasia.

Authors:  L Giannone; F A Greco; J D Hainsworth
Journal:  J Clin Oncol       Date:  1986-01       Impact factor: 44.544

2.  Neurotoxicity and elevated cerebrospinal-fluid methotrexate concentration in meningeal leukemia.

Authors:  W A Bleyer; J C Drake; B A Chabner
Journal:  N Engl J Med       Date:  1973-10-11       Impact factor: 91.245

3.  Bilateral profound hearing loss due to meningeal carcinomatosis.

Authors:  Michiel Wagemakers; Wim Verhagen; Bas van de Borne; Dick Venderink; Carla Wauters; Luc Strobbe
Journal:  J Clin Neurosci       Date:  2005-04       Impact factor: 1.961

4.  Meningeal carcinomatosis: an unusual cause of deafness.

Authors:  M K Morgan; I Zammit-Maempel; J Hill
Journal:  J R Coll Surg Edinb       Date:  1998-04

5.  A prospective randomized trial of single-agent versus combination chemotherapy in meningeal carcinomatosis.

Authors:  R N Hitchins; D R Bell; R L Woods; J A Levi
Journal:  J Clin Oncol       Date:  1987-10       Impact factor: 44.544

6.  [A case of meningeal carcinomatosis presenting with bilateral hearing loss].

Authors:  Yoko Okamoto; Hiromichi Sugiyama; Toru Yamamoto
Journal:  Brain Nerve       Date:  2007-12

7.  Sudden bilateral profound hearing loss resulting from meningeal carcinomatosis.

Authors:  J R Houck; K Murphy
Journal:  Otolaryngol Head Neck Surg       Date:  1992-01       Impact factor: 3.497

8.  Meningeal carcinomatosis producing bilateral sudden hearing loss: a case report.

Authors:  F Civantos; Y S Choi; E L Applebaum
Journal:  Am J Otol       Date:  1992-07

9.  Phase I/II study of S-1 combined with paclitaxel in patients with unresectable and/or recurrent advanced gastric cancer.

Authors:  E Mochiki; T Ohno; Y Kamiyama; R Aihara; N Haga; H Ojima; J Nakamura; H Ohsawa; T Nakabayashi; K Takeuchi; T Asao; H Kuwano
Journal:  Br J Cancer       Date:  2006-11-28       Impact factor: 7.640

Review 10.  Neoplastic meningitis.

Authors:  L Kim; M J Glantz
Journal:  Curr Treat Options Oncol       Date:  2001-12
View more
  12 in total

1.  Frequent development of leptomeningeal carcinomatosis in patients with peritoneal dissemination of gastric cancer.

Authors:  Shigenobu Emoto; Hironori Ishigami; Hironori Yamaguchi; Hiroharu Yamashita; Shoichi Kaisaki; Joji Kitayama
Journal:  Gastric Cancer       Date:  2011-06-11       Impact factor: 7.370

2.  Leptomeningeal carcinomatosis as the initial manifestation of gastric adenocarcinoma: a case report.

Authors:  Jian-Wen Guo; Xiao-Tian Zhang; Xiao-Sheng Chen; Xin-Chun Zhang; Guang-Juan Zheng; Bei-Ping Zhang; Ye-Feng Cai
Journal:  World J Gastroenterol       Date:  2014-02-28       Impact factor: 5.742

3.  Predicting liver metastasis of gastrointestinal tract cancer by diffusion-weighted imaging of apparent diffusion coefficient values.

Authors:  De-Xian Zheng; Shu-Chun Meng; Qing-Jun Liu; Chuan-Ting Li; Xi-Dan Shang; Yu-Seng Zhu; Tian-Jun Bai; Shi-Ming Xu
Journal:  World J Gastroenterol       Date:  2016-03-14       Impact factor: 5.742

4.  Lung adenocarcinoma metastastic lesion in the internal auditory meatus.

Authors:  Eugene Hung Chih Wong; Daniel Bodmer; Nora Tetter; Yves Brand
Journal:  BMJ Case Rep       Date:  2017-10-20

5.  Sudden bilateral hearing loss in gastric cancer as the only symptom of disease.

Authors:  Zoran Rakusic; Ana Misir Krpan; Darija Stupin Polancec; Antonia Jakovcevic; Vesna Bisof
Journal:  Onco Targets Ther       Date:  2015-06-02       Impact factor: 4.147

6.  Hearing loss due to metastasis of gastric cancer to temporal bone: A case report.

Authors:  Xiangming Cao; Fangbo Cui; Jia Wei; Qing Wang; Li Chun Deng; Bao Rui Liu; Wei Sheng Shen
Journal:  Oncol Lett       Date:  2016-01-08       Impact factor: 2.967

Review 7.  Intracranial hypertension as the primary symptom of gastric signet-ring cell carcinoma: A case report and literature review.

Authors:  Jiali Pu; Lingjia Xu; Xinzhen Yin; Baorong Zhang
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

8.  Leptomeningeal Carcinomatosis in Gastric Cancer: A Therapeutical Challenge.

Authors:  Maria Vergoulidou
Journal:  Biomark Insights       Date:  2017-03-16

9.  miR‑204‑5p promotes apoptosis and inhibits migration of gastric cancer cells by targeting HER‑2.

Authors:  Shu Yang; Binni Chen; Baogen Zhang; Caiping Li; Yuena Qiu; Hanhui Yang; Zhongxin Huang
Journal:  Mol Med Rep       Date:  2020-07-28       Impact factor: 2.952

10.  Co-occurrence of multiple cerebral infarctions due to hypercoagulability associated with malignancy and meningeal carcinomatosis as the initial manifestation of gastric cancer.

Authors:  Akiko Kawasaki; Keisuke Suzuki; Hidehiro Takekawa; Toshiki Nakamura; Masanari Yamamoto; Yohei Asakawa; Madoka Okamura; Koichi Hirata
Journal:  BMC Neurol       Date:  2014-08-08       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.